• Home
  •  / Sucampo Pharmaceuticals
ProfileJobs

Sucampo Pharmaceuticals

Suggest Edit
Healthcareclinicspharma

Sucampo Pharmaceuticals is a global biopharmaceutical company focused on innovative research and development of proprietary drugs to treat gastrointestinal, ophthalmic and oncology-based inflammatory disorders. Sucampo has a marketed product - AMITIZA® - and a pipeline including lifecycle management and clinical development programs. Sucampo is headquartered in Rockville, Maryland, and has operations in Japan, Switzerland and the United Kingdom.

Revenue(FY, 2016)
$230.1 M

Employee Rating

3.2More
StateClosed
TypeSubsidiary
Parent CompanyMallinckrodt Pharmaceuticals
HQRockville, US
Founded1996
Websitesucampo.com
Sucampo Pharmaceuticals was founded in 1996 and is headquartered in Rockville, US

Viewing summary data as a guest

Sign up for free to see all data

Sucampo Pharmaceuticals Office Locations

Sucampo Pharmaceuticals has offices in Rockville, Chiyoda, Chuo Ward, Kita Ward and in 3 other locations
Rockville, US (HQ)
805 King Farm Blvd #550
Chiyoda, JP
NBF Hibiya Building, 10th Floor 1-1-7 Uchisaiwaicho
Chuo Ward, JP
Kobe Hybrid Business Center, 3rd Floor 6-7-6 Minatojima Minamimachi, Chuo-ku, Kobe City
Kita Ward, JP
Nishiumeda MID Building, 4th Floor 2-2-16 Sonezakishinchi
Sanda-shi, JP
4-1 Techno-Park
Zug, CH
22 Baarerstrasse
Show all (7)

Sucampo Pharmaceuticals Financials and Metrics

Summary Metrics

Founding Date

1996
Sucampo Pharmaceuticals is a subsidiary of Mallinckrodt Pharmaceuticals

Sucampo Pharmaceuticals Revenue

Sucampo Pharmaceuticals's revenue was reported to be $230.06 m in FY, 2016 which is a 50.2% increase from the previous period.
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

54.8m81.5m89.6m115.5m153.2m230.1m

Revenue growth, %

29%33%50%

Cost of goods sold

3.0m12.4m16.3m36.7m76.0m

Gross profit

78.5m77.2m99.2m116.4m154.1m
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

14.0m14.4m14.4m16.7m15.5m16.9m27.0m21.2m22.2m24.1m31.5m29.5m34.9m33.4m47.2m52.0m57.9m56.3m59.9m61.3m

Cost of goods sold

1.3m1.9m6.3m3.5m3.8m5.0m6.1m7.3m5.3m23.3m20.4m15.6m16.9m17.0m17.4m

Gross profit

15.6m25.1m14.9m18.6m20.3m26.5m23.4m27.6m28.2m23.9m31.6m42.3m39.4m42.9m43.8m

Gross profit Margin, %

92%93%70%84%84%84%79%79%84%51%61%73%70%72%72%
show all
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Cash

50.7m52.0m44.1m71.6m108.3m198.3m

Accounts Receivable

4.6m1.4m5.4m5.3m22.8m43.0m

Prepaid Expenses

1.2m1.9m4.0m3.4m8.9m

Inventories

209.0k33.1m23.5m
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

52.3m55.3m55.5m61.7m57.2m48.6m47.3m39.9m56.1m53.5m56.1m59.6m71.3m91.5m130.1m128.0m128.5m243.5m84.7m75.0m

Accounts Receivable

732.0k1.1m1.1m606.0k1.2m1.8m3.6m2.7m4.4m4.8m8.5m8.2m8.2m6.7m16.1m18.2m20.7m20.5m19.8m33.1m

Prepaid Expenses

1.6m1.7m1.8m1.6m2.6m2.7m3.9m3.8m3.6m3.4m3.6m2.9m2.8m3.7m14.1m24.3m18.1m16.7m16.7m34.7m

Inventories

4.0m4.9m261.0k455.0k423.0k133.0k328.0k308.0k296.0k24.4m21.6m24.2m23.0m23.1m24.2m
show all
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(17.3m)4.8m6.4m13.1m33.4m18.5m

Depreciation and Amortization

1.3m1.5m1.5m1.1m10.6m45.7m

Inventories

(127.0k)87.0k(163.0k)206.0k(1.4m)(1.2m)

Accounts Payable

2.9m(1.5m)2.2m(3.4m)(1.7m)(2.8m)
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

(15.9m)(20.0m)(1.9m)(2.7m)(8.7m)(3.1m)3.0m4.3m675.0k2.4m3.8m6.4m16.0m23.2m(4.1m)(4.9m)3.2m4.6m(176.5m)(166.2m)

Depreciation and Amortization

650.0k1.0m350.0k731.0k1.1m381.0k753.0k1.1m361.0k721.0k984.0k83.0k215.0k433.0k15.6m30.1m37.9m7.4m14.9m22.4m

Inventories

2.0k87.0k87.0k(3.9m)(4.8m)(218.0k)(245.0k)(211.0k)74.0k(328.0k)(308.0k)(296.0k)1.8m309.0k(2.0m)490.0k370.0k(708.0k)

Accounts Payable

(50.0k)2.1m(1.3m)(1.6m)(3.5m)3.9m294.0k(2.4m)(1.6m)(2.0m)(1.7m)(2.7m)(221.0k)785.0k(6.3m)(5.8m)(4.1m)(1.2m)458.0k(4.5m)
show all
Show all financial metrics

Sucampo Pharmaceuticals Online and Social Media Presence

Sucampo Pharmaceuticals's Trends

Embed Graph

 Sucampo Pharmaceuticals Frequently Asked Questions

  • When was Sucampo Pharmaceuticals founded?

    Sucampo Pharmaceuticals was founded in 1996.

  • What is Sucampo Pharmaceuticals revenue?

    Latest Sucampo Pharmaceuticals annual revenue is $230.1 m.

  • Who are Sucampo Pharmaceuticals competitors?

    Competitors of Sucampo Pharmaceuticals include BTG, Zogenix and Array BioPharma.

  • Where is Sucampo Pharmaceuticals headquarters?

    Sucampo Pharmaceuticals headquarters is located at 805 King Farm Blvd #550, Rockville.

  • Where are Sucampo Pharmaceuticals offices?

    Sucampo Pharmaceuticals has offices in Rockville, Chiyoda, Chuo Ward, Kita Ward and in 3 other locations.

  • How many offices does Sucampo Pharmaceuticals have?

    Sucampo Pharmaceuticals has 7 offices.